Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Biolato

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2013
A phase II study of sunitinib in advanced hepatocellular carcinomaCarlo Barone, Michele Basso, Marco Biolato, et al.
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
World Journal of Gastroenterology|July 11, 2014
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survivalMarco Biolato, Luca Miele, Vittoria Vero, et al.
Transplantation Reviews (Orlando, Fla.)|February 28, 2024
The role of echocardiographic assessment for the risk of adverse events in liver transplant recipients: A systematic review and meta-analysisQuirino Lai, Miriam Caimano, Francesca Canale, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 19, 2020
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver diseaseLuca Miele, Valentina Giorgio, Antonio Liguori, et al.
Annals of Hepatology|January 22, 2021
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohortCristina Lucidi, Marco Biolato, Quirino Lai, et al.
World Journal of Transplantation|June 19, 2025
Diagnostic accuracy and cost-effectiveness of the CAR-OLT score in predicting cardiac risk for liver transplantationMarco Biolato, Luca Miele, Alfonso W Avolio, et al.
Annals of Hepatology|January 10, 2018
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationMarco Biolato, Giulia Gallusi, Massimo Iavarone, et al.
Journal of Clinical and Experimental Hepatology|June 17, 2026
Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score AnalysisMarco Biolato, Quirino Lai, Tiziano Galasso, et al.
Journal of Medical Genetics|September 17, 2025
GAPO syndrome: a comprehensive examination and review of 105 clinical casesClarissa Modafferi, Pino D'Ambrosio, Silvia Andaloro, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 16, 2013
A phase II study of sunitinib in advanced hepatocellular carcinomaCarlo Barone, Michele Basso, Marco Biolato, et al.
The International Journal of Biological Markers|September 2, 2017
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical settingLuca Miele, Teresa De Michele, Giuseppe Marrone, et al.
World Journal of Gastroenterology|July 11, 2014
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survivalMarco Biolato, Luca Miele, Vittoria Vero, et al.
Transplantation Reviews (Orlando, Fla.)|February 28, 2024
The role of echocardiographic assessment for the risk of adverse events in liver transplant recipients: A systematic review and meta-analysisQuirino Lai, Miriam Caimano, Francesca Canale, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 19, 2020
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver diseaseLuca Miele, Valentina Giorgio, Antonio Liguori, et al.
Annals of Hepatology|January 22, 2021
Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohortCristina Lucidi, Marco Biolato, Quirino Lai, et al.
World Journal of Transplantation|June 19, 2025
Diagnostic accuracy and cost-effectiveness of the CAR-OLT score in predicting cardiac risk for liver transplantationMarco Biolato, Luca Miele, Alfonso W Avolio, et al.
Annals of Hepatology|January 10, 2018
Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationMarco Biolato, Giulia Gallusi, Massimo Iavarone, et al.
Journal of Clinical and Experimental Hepatology|June 17, 2026
Liver Transplant Outcomes in Patients With Transjugular Intrahepatic Portosystemic Shunt: A Retrospective Cohort Study With Propensity Score AnalysisMarco Biolato, Quirino Lai, Tiziano Galasso, et al.
Journal of Medical Genetics|September 17, 2025
GAPO syndrome: a comprehensive examination and review of 105 clinical casesClarissa Modafferi, Pino D'Ambrosio, Silvia Andaloro, et al.
Pageof 6